左旋苯丙胺的药理学特征:G蛋白偏向性阿片类镇痛药
本文通过体外受体结合与功能实验及小鼠体内镇痛研究,评估左旋苯丙胺的药理学特性。结果显示其对μ、δ、κ阿片受体均有高亲和力,在多数μ受体亚型为完全激动剂,但β-arrestin2募集活性低,提示G蛋白信号偏向性。左旋苯丙胺镇痛经经典μ受体介导,并涉及6跨膜受体变异体贡献。等镇痛剂量下呼吸抑制较吗啡轻,与吗啡交叉耐受不完全。
要点
- 左旋苯丙胺对μ、δ、κ阿片受体均有高亲和力。
- 在多数μ受体亚型为完全激动剂,β-arrestin2募集活性低,呈G蛋白偏向性。
- 等镇痛剂量下呼吸抑制较吗啡轻,与吗啡交叉耐受不完全。
核心结论
- 左旋苯丙胺与经典阿片类药物吗啡性质相似,但存在微妙差异,可能有助于临床使用。
- 其G蛋白信号偏向性与呼吸抑制减轻一致,与吗啡交叉耐受不完全提示阿片轮换可能有益。
研究设计与样本
- 体外受体结合与功能测定,以及体内辐射热甩尾镇痛实验。
- 采用基因敲除小鼠、选择性拮抗剂和病毒拯救方法探索受体选择性。
主要发现
- 受体结合研究显示左旋苯丙胺对μ、δ、κ阿片受体均有高亲和力。
- 在S-GTPγS结合实验中,除MOR-1O外,左旋苯丙胺在多数μ受体亚型为完全激动剂,但在β-arrestin2募集实验中活性很低。
- 基因敲除小鼠和选择性拮抗剂证实左旋苯丙胺镇痛由经典μ受体介导,但外显子11敲除小鼠反应降低及病毒转染6跨膜受体剪接变异体可拯救,提示6跨膜靶点有贡献。
- 与吗啡相比,左旋苯丙胺在等镇痛剂量下呼吸抑制更少。
临床怎么用
- 左旋苯丙胺的G蛋白偏向性可能解释其呼吸抑制较轻,临床使用中需关注。
- 与吗啡交叉耐受不完全,提示在阿片轮换时可能具有价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Levorphanol is a potent analgesic that has been used for decades. Most commonly used for acute and cancer pain, it also is effective against neuropathic pain. The recent appreciation of the importance of functional bias and the uncovering of multiple µ opioid receptor splice variants may help explain the variability of patient responses to different opioid drugs. METHODS: Here, we evaluate levorphanol in a variety of traditional in vitro receptor binding and functional assays. In vivo analgesia studies using the radiant heat tail flick assay explored the receptor selectivity of the responses through the use of knockout (KO) mice, selective antagonists, and viral rescue approaches. RESULTS: Receptor binding studies revealed high levorphanol affinity for all the μ, δ, and κ opioid receptors. In S-GTPγS binding assays, it was a full agonist at most µ receptor subtypes, with the exception of MOR-1O, but displayed little activity in β-arrestin2 recruitment assays, indicating a preference for G-protein transduction mechanisms. A KO mouse and selective antagonists confirmed that levorphanol analgesia was mediated through classical µ receptors, but there was a contribution from 6 transmembrane targets, as illustrated by a lower response in an exon 11 KO mouse and its rescue with a virally transfected 6 transmembrane receptor splice variant. Compared to morphine, levorphanol had less respiratory depression at equianalgesic doses. CONCLUSIONS: While levorphanol shares many of the same properties as the classic opioid morphine, it displays subtle differences that may prove helpful in its clinical use. Its G-protein signaling bias is consistent with its diminished respiratory depression, while its incomplete cross tolerance with morphine suggests it may prove valuable clinically with opioid rotation.
引用
- Le Rouzic V, Narayan A, Hunkle A, et al. Pharmacological Characterization of Levorphanol, a G-Protein Biased Opioid Analgesic. Anesth Analg. 2019. PMID: 29649035. doi:10.1213/ANE.0000000000003360
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。